Mandy Cohen, the new director of the Centers for Disease Control and Prevention, earned praise for her leadership and communication as the face of North Carolina’s response to covid-19. People in the state’s most vulnerable communities tell a more complicated story.
Mental health is being talked about more openly than ever, but the word “suicide” has remained largely taboo when describing how someone died. See why that’s slowly changing, what it means for people who grieve those deaths, and how candor can help prevent additional suicides.
A new poll from KFF shows many Americans aren’t willing to embrace misinformation — but aren’t willing to reject it either. And they don’t know whom to trust.
Chagas disease, caused by a parasite, affects people primarily in rural Latin America. But an estimated 300,000 residents of the U.S. have the disease, which can cause serious heart problems. Patient advocates call for much more aggressive efforts to fight it.
No local hospital and anemic ambulance services mean residents in rural Pickens County, Alabama, are thrown into perilous situations when they have medical emergencies. It’s a kind of medical care roulette that has become a fact of life for rural Americans who live in ambulance deserts.
In early 2020, U.S. public health labs received covid-19 tests from the Centers for Disease Control and Prevention that were flawed, as a result of poor design and contamination. Now the CDC is overhauling its lab operations, but efforts to be better prepared for future threats won’t be easy, observers say.
Community health workers, who often help patients get to their appointments and pick up prescriptions for them, have increasingly been recognized as an integral part of treating chronic illnesses. But state-run Medicaid programs don’t always reimburse them equally, usually excluding those who work on tribal lands.
Brand-name drug prices in the U.S. — more than three times the price in other developed countries — are related neither to the amount of research and development required to bring them to market nor their therapeutic value, recent research shows. Have drugmakers overplayed their hand?
The federal government is proposing having Medicare pay professionals to train family caregivers how to perform tasks like bathing and dressing their loved ones, and properly use medical equipment.
A federal appeals court issued a split decision on whether the abortion pill mifepristone should remain on the market — rejecting a lower court’s decision to effectively cancel the drug’s FDA approval in 2000, while ordering the rollback of more recent rules that made the drug easier to obtain. Nothing changes immediately, however, as the Supreme Court blocked the lower court’s ruling in the spring. It will be up to the high court to determine whether the pill remains available in the U.S. and under which conditions. Sarah Karlin-Smith of the Pink Sheet, Alice Miranda Ollstein of Politico, and Shefali Luthra of The 19th join KFF Health News’ chief Washington correspondent, Julie Rovner, to discuss these issues and more. Plus, for “extra credit,” the panelists suggest health policy stories they read this week they think you should read, too.
